These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 15814163)
1. Importance of Metalloproteinase Enzyme Group in Selected Skeletal System Diseases. Kulesza M; Kicman A; Motyka J; Guszczyn T; Ławicki S Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138968 [TBL] [Abstract][Full Text] [Related]
2. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Wells GA; Hsieh SC; Zheng C; Peterson J; Tugwell P; Liu W Cochrane Database Syst Rev; 2022 May; 5(5):CD004523. PubMed ID: 35502787 [TBL] [Abstract][Full Text] [Related]
3. IL-18-Mediated SLC7A5 Overexpression Enhances Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells Ni F; Zhang T; Xiao W; Dong H; Gao J; Liu Y; Li J Front Cell Dev Biol; 2021; 9():748831. PubMed ID: 34977008 [No Abstract] [Full Text] [Related]
4. Effects of 12-Week Exercise Program on Enzyme Activity of Serum Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Female Patients with Postmenopausal Osteoporosis: A Randomized Control Study. Filipović T; Gopčević K; Dimitrijević S; Hrković M; Backović A; Lazović M Biomed Res Int; 2020; 2020():9758289. PubMed ID: 32071923 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview. Ilesanmi-Oyelere BL; Schollum L; Kuhn-Sherlock B; McConnell M; Mros S; Coad J; Roy NC; Kruger MC Immun Ageing; 2019; 16():15. PubMed ID: 31333751 [TBL] [Abstract][Full Text] [Related]
6. The Role of Macrophage in the Pathogenesis of Osteoporosis. Yang DH; Yang MY Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035384 [TBL] [Abstract][Full Text] [Related]
7. Transforming Growth Factor β1 (TGF-β1) in the Sera of Postmenopausal Osteoporotic Females. Faraji A; Abtahi S; Ghaderi A; Samsami Dehaghani A Int J Endocrinol Metab; 2016 Oct; 14(4):e36511. PubMed ID: 28123435 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo. Sandholm J; Lehtimäki J; Ishizu T; Velu SE; Clark J; Härkönen P; Jukkola-Vuorinen A; Schrey A; Harris KW; Tuomela JM; Selander KS Oncotarget; 2016 Dec; 7(52):87373-87389. PubMed ID: 27888633 [TBL] [Abstract][Full Text] [Related]
9. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?]. MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093 [No Abstract] [Full Text] [Related]
10. Interleukin-18 (IL-18) and matrix metalloproteinase-9 (MMP-9) in post-menopausal osteoporosis. Maugeri D; Mamazza C; Lo Giudice F; Puglisi N; Muscoso EG; Rizzotto M; Testaì M; Bennati E; Lentini A; Panebianco P Arch Gerontol Geriatr; 2005; 40(3):299-305. PubMed ID: 15814163 [TBL] [Abstract][Full Text] [Related]
11. Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study. Muscoso E; Puglisi N; Mamazza C; Lo Giudice F; Testai M; Abbate S; Santangelo A; Panebianco P; Maugeri D Eur Rev Med Pharmacol Sci; 2004; 8(2):97-102. PubMed ID: 15267123 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis. Iwamoto J; Takeda T; Sato Y Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313 [TBL] [Abstract][Full Text] [Related]